Skip to content

Clinical trials

Completed Vulvar Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vulvar Neoplasms Status: Completed Clear all

103 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20035
20043
20053
20063
20078
20083
20097
20104
20117
20123
20132
20141
20152
20163
20174
20187
20194
20206
20214
20227
20232
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed103

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC9
Gynecologic Oncology Group6
National Cancer Institute (NCI)6
Ohio State University Comprehensive Cancer Center4
Royal Marsden NHS Foundation Trust4
Alliance for Clinical Trials in Oncology3
Memorial Sloan Kettering Cancer Center3
Shanghai Bovax Biotechnology Co., Ltd.3
Abramson Cancer Center at Penn Medicine2
Beijing Health Guard Biotechnology, Inc2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vulvar Neoplasms103
Uterine Cervical Neoplasms82
Vaginal Neoplasms63
Endometrial Neoplasms39
Ovarian Neoplasms34
Fallopian Tube Neoplasms28
Anus Neoplasms24
Breast Neoplasms20
Carcinoma, Ovarian Epithelial20
Penile Neoplasms19

Trials

Showing 1 to 25 of 103. Each trial links to its page on Pharma Observatory.

3 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.